STOCK TITAN

EXEL insider ownership: SVP & General Counsel discloses share holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Exelixis, Inc. officer reports beneficial ownership of company stock. The SVP and General Counsel is shown as beneficially owning 90,441 shares of Exelixis common stock directly, including 80,575 shares that will be issued upon vesting of restricted stock units and performance-based restricted stock units, and 556 shares acquired under the company’s 2000 Employee Stock Purchase Plan. In addition, 5,527 shares are held indirectly through the Exelixis 401(k) Plan as of November 7, 2025.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Hefti Brenda

(Last) (First) (Middle)
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY

(Street)
ALAMEDA CA 94502

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/07/2025
3. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and General Counsel
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 90,441(1)(2) D
Common Stock 5,527 I By 401(k)(3)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 80,575 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.
2. Includes 556 shares acquired under the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
3. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 7, 2025.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Nina Ayer, Attorney in Fact 11/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Exelixis (EXEL) shares does the SVP and General Counsel beneficially own directly?

The SVP and General Counsel is reported as directly beneficially owning 90,441 shares of Exelixis common stock. This figure includes shares underlying restricted stock units and performance-based restricted stock units, as well as shares acquired under the employee stock purchase plan.

What portion of the Exelixis (EXEL) holdings are in RSUs and PSUs for this officer?

The filing states that 80,575 shares of Exelixis common stock will be issued upon vesting of restricted stock units (RSUs) and performance-based restricted stock units (PSUs), and these are included in the reported direct beneficial ownership.

How many Exelixis (EXEL) shares were acquired under the Employee Stock Purchase Plan?

The officer’s direct holdings include 556 shares of Exelixis common stock that were acquired under the Exelixis, Inc. 2000 Employee Stock Purchase Plan.

How many Exelixis (EXEL) shares does the officer hold indirectly through the 401(k) Plan?

The officer is reported as indirectly beneficially owning 5,527 shares of Exelixis common stock through the Exelixis, Inc. 401(k) Plan, based on a plan statement dated November 7, 2025.

What is the officer’s role and relationship to Exelixis (EXEL)?

The reporting person is identified as an officer of Exelixis, Inc., serving as SVP and General Counsel, and the filing reports this individual’s beneficial ownership of Exelixis common stock.

Does the filing include any derivative securities for the Exelixis (EXEL) officer?

The section for derivative securities is presented, but in the provided content there are no specific derivative securities listed with dates, exercise prices, or share amounts.

Exelixis Inc

NASDAQ:EXEL

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

12.18B
262.25M
2.23%
96.96%
6.55%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
ALAMEDA